CTIC CTI BioPharma Corp

CTI BioPharma Corp is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of novel targeted therapies.

$1.61
As of 12/03/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2001
Outstanding shares:  96,692,424
Average volume:  3,305,234
Market cap:   $139,237,091
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    12648L601
ISIN:        US12648L6011
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   4.01
PS ratio:   0.00
Return on equity:   -195.75%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy